BACKGROUND: Measurements of HIV exposure could help identify subpopulations at highest risk of acquisition and improve the design of HIV prevention efficacy trials and public health interventions. The HVTN 915 study evaluated the feasibility of self-administered vaginal swabs for detection of HIV virions to assess exposure. METHODS: Fifty 18- to 25-year-old sexually active HIV-seronegative women using contraception were enrolled in Soweto, South Africa. Participants self-administered daily vaginal swabs and answered sexual behavior questions through mobile phone for 90 days. Clinician-administered vaginal swabs, behavioral questionnaires, HIV diagnostic testing, and counseling were performed at 8 clinic visits. Glycogen concentrations assessed adherence to swabbing. Y-chromosome DNA (Yc-DNA) assessed the accuracy of reported condom use. HIV exposure was measured by virion polymerase chain reaction in swabs from 41 women who reported unprotected vaginal sex during follow-up. RESULTS: Glycogen was detected in 315/336 (93.8%) participant-collected and in all clinician-collected swabs. Approximately 20/39 daily swabs (51.3%) linked to mobile reports of unprotected sex tested positive for Yc-DNA, whereas 10/187 swabs collected after 3 days of abstinence or protected sex (5.3%) had detectable Yc-DNA. No participant became HIV infected during the study; yet, exposure to HIV was detected by nucleic acids in 2 vaginal swabs from 1 participant, collected less than 1 hour after coitus. CONCLUSION: There was high adherence to daily vaginal swabbing. Daily mobile surveys had accurate reporting of unprotected sex. Detection of HIV in self-collected vaginal swabs from an uninfected participant demonstrated it was possible to measure HIV exposure, but the detection rate was lower than expected.
BACKGROUND: Measurements of HIV exposure could help identify subpopulations at highest risk of acquisition and improve the design of HIV prevention efficacy trials and public health interventions. The HVTN 915 study evaluated the feasibility of self-administered vaginal swabs for detection of HIV virions to assess exposure. METHODS: Fifty 18- to 25-year-old sexually active HIV-seronegative women using contraception were enrolled in Soweto, South Africa. Participants self-administered daily vaginal swabs and answered sexual behavior questions through mobile phone for 90 days. Clinician-administered vaginal swabs, behavioral questionnaires, HIV diagnostic testing, and counseling were performed at 8 clinic visits. Glycogen concentrations assessed adherence to swabbing. Y-chromosome DNA (Yc-DNA) assessed the accuracy of reported condom use. HIV exposure was measured by virion polymerase chain reaction in swabs from 41 women who reported unprotected vaginal sex during follow-up. RESULTS:Glycogen was detected in 315/336 (93.8%) participant-collected and in all clinician-collected swabs. Approximately 20/39 daily swabs (51.3%) linked to mobile reports of unprotected sex tested positive for Yc-DNA, whereas 10/187 swabs collected after 3 days of abstinence or protected sex (5.3%) had detectable Yc-DNA. No participant became HIV infected during the study; yet, exposure to HIV was detected by nucleic acids in 2 vaginal swabs from 1 participant, collected less than 1 hour after coitus. CONCLUSION: There was high adherence to daily vaginal swabbing. Daily mobile surveys had accurate reporting of unprotected sex. Detection of HIV in self-collected vaginal swabs from an uninfected participant demonstrated it was possible to measure HIV exposure, but the detection rate was lower than expected.
Authors: M J Wawer; R H Gray; N K Sewankambo; D Serwadda; L Paxton; S Berkley; D McNairn; F Wabwire-Mangen; C Li; F Nalugoda; N Kiwanuka; T Lutalo; R Brookmeyer; R Kelly; T C Quinn Journal: AIDS Date: 1998-07-09 Impact factor: 4.177
Authors: Barbara S Mensch; Paul C Hewett; Sharon Abbott; Johanna Rankin; Sarah Littlefield; Khatija Ahmed; Nazira Cassim; Smruti Patel; Gita Ramjee; Thesla Palanee; Stan Mierzwa; Stephanie Skoler-Karpoff Journal: AIDS Behav Date: 2011-02
Authors: Max A Chernesky; Edward W Hook; David H Martin; Jeannine Lane; Randy Johnson; Jeanne A Jordan; Deanna Fuller; Dean E Willis; Paul M Fine; William M Janda; Julius Schachter Journal: Sex Transm Dis Date: 2005-12 Impact factor: 2.830
Authors: Maria F Gallo; Frieda M Behets; Markus J Steiner; Marcia M Hobbs; Theresa Hatzell Hoke; Kathleen Van Damme; Louisette Ralimamonjy; Leonardine Raharimalala; Myron S Cohen Journal: Sex Transm Dis Date: 2006-08 Impact factor: 2.830
Authors: Eve Rose; Ralph J Diclemente; Gina M Wingood; Jessica McDermott Sales; Teaniese P Latham; Richard A Crosby; Jonathan Zenilman; Johan Melendez; James Hardin Journal: Arch Pediatr Adolesc Med Date: 2009-01
Authors: Andrea Thurman; Terry Jacot; Johan Melendez; Thomas Kimble; Margaret Snead; Roxanne Jamshidi; Angie Wheeless; David F Archer; Gustavo F Doncel; Christine Mauck Journal: Contraception Date: 2016-05-31 Impact factor: 3.375
Authors: Julius Schachter; William M McCormack; Max A Chernesky; David H Martin; Barbara Van Der Pol; Peter A Rice; Edward W Hook; Walter E Stamm; Thomas C Quinn; Joan M Chow Journal: J Clin Microbiol Date: 2003-08 Impact factor: 5.948
Authors: Maria P Lemos; Vijay Nandi; Joan Dragavon; Ira Fleming; Keertana Krishnan; Martin Musuruana; Madeline Kramer; Hayley Glantz; Michele Andrasik; Robert W Coombs; M Juliana McElrath; Hong-Van Tieu Journal: J Acquir Immune Defic Syndr Date: 2021-10-01 Impact factor: 3.771
Authors: Janan J Dietrich; Gabriella L Benadé; Mamakiri Mulaudzi; Ashraf Kagee; Stefanie Hornschuh; Lerato M Makhale; Maria P Lemos; Erica Lazarus; Michele P Andrasik; Keith J Horvath Journal: Front Digit Health Date: 2021-03-22